(Q51026715)

English

FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft.

scientific article published on 8 December 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

1 reference

based on heuristic

inferred from title

Bernard Vanhove

15

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

author name string

N Poirier

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

N Dilek

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

C Mary

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

S Ville

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

F Coulon

5

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

J Branchereau

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

X Tillou

7

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

V Charpy

8

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

S Pengam

9

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

V Nerriere-Daguin

10

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

J Hervouet

11

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

D Minault

12

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

S Le Bas-Bernardet

13

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

K Renaudin

14

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

G Blancho

16

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

language of work or name

0 references

publication date

8 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

American Journal of Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

15

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

88-100

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

Blood pressure and graft outcome in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

The natural history of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

A more selective costimulatory blockade of the CD28-B7 pathway.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Costimulation blockade with belatacept in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Alternatives to calcineurin inhibition in renal transplantation: belatacept, the first co-stimulation blocker.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

CD28-specific immunomodulating antibodies: what can be learned from experimental models?

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Interaction of human PD-L1 and B7-1.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

B7-h2 is a costimulatory ligand for CD28 in human

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

FR255734, a humanized, Fc-Silent, Anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Antagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domain

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Recombinant human C1-inhibitor inhibits cytotoxicity induced by allo- and xenoantibodies

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

The spectrum of antibody-mediated renal allograft injury: implications for treatment

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Signals that influence T follicular helper cell differentiation and function.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

CTLA-4 control over Foxp3+ regulatory T cell function

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

tTregs, pTregs, and iTregs: similarities and differences

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibody

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12964

21 January 2018

Identifiers

10.1111/AJT.12964

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25488654

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51026715&oldid=1254218447"